Dyne Biopharma's operational performance for 2022 hits new high

Summary: The operating performance of Dyne Biopharma for 2022 hit new high, with operating revenue growing by 38.58% YoY and net profit climbing by 46.55% YoY.On 11 March, Shandong Wit Dyne Health Co., Ltd. (Wit Dyne Health) issued the annual perform...

Vitamins China E-News 202303

www.cnchemicals.com